S. Tyring

BRAF inhibitor‐associated cutaneous squamous cell carcinoma: new mechanistic insight, emerging evidence for viral involvement and perspectives on clinical management

Julie H Wu, P. Rady, D. N. Cohen, 2017, The British journal of dermatology.

A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction

A. Nakanishi, K. Papp, M. Lahfa, 2005, The British journal of dermatology.

Efficacy of tildrakizumab for moderate‐to‐severe plaque psoriasis: pooled analysis of three randomized controlled trials at weeks 12 and 28

S. Green, M. Gooderham, K. Papp, 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

Safety of tildrakizumab for moderate‐to‐severe plaque psoriasis: pooled analysis of three randomized controlled trials

A. Kimball, S. Green, M. Gooderham, 2018, The British journal of dermatology.

Patient‐reported outcomes in moderate‐to‐severe plaque psoriasis with scalp involvement: results from a randomized, double‐blind, placebo‐controlled study of etanercept

S. Tyring, C. Lynde, G. Kricorian, 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

Secukinumab demonstrates greater sustained improvements in daily activities and personal relationships than ustekinumab in patients with moderate‐to‐severe plaque psoriasis: 52‐week results from the CLEAR study

F. Vanaclocha, K. Reich, A. Blauvelt, 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

Open‐label study of etanercept treatment in patients with moderate‐to‐severe plaque psoriasis who lost a satisfactory response to adalimumab

D. Collier, S. Tyring, G. Kricorian, 2017, The British journal of dermatology.

The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study†

L. Denis, S. Forman, J. Fowler, 2019, The British journal of dermatology.

Generalized verrucosis in a patient with GATA2 deficiency

S. Holland, A. Hsu, S. Tyring, 2014, The British journal of dermatology.